Because cannabis use was recently legalized in New York State, this research strives to gain an improved understanding of substance use prevalence and related risk and resiliency factors among young adults in New York State. Contact: UB-Cannabis@buffalo.edu
CRIA is UB's hub for bright, passionate scientists working on addiction and addiction-related topics. They work in a culture of scientific and organizational support that nurtures creativity and research success.
Our Addiction Treatment Services (ATS) is the only treatment program in New York State designed specifically for clinical research and plays a fundamental role in the Institute’s ability to test, apply and monitor innovative treatment strategies.
We share knowledge with other researchers, treatment providers, legislators and the public to aid understanding of addiction-related issues through regular news releases, seminars, conferences and our Expert Summaries series.
The Clinical and Research Institute on Addictions anticipates three postdoctoral positions on the NIAAA-funded T32 training grant beginning next summer. Mentors who will be available and their areas of research are listed here.
Samir Haj-Dahmane, PhD, and Roh-Yu Shen, PhD, each received five-year, $1.8 million grants from the National Institute on Alcoholism and Alcohol Abuse (NIAAA) to study fetal alcohol spectrum disorders (FASD) and how prenatal alcohol exposure affects the brain.
The University at Buffalo was selected by the U.S. Department of State’s Bureau of Educational and Cultural Affairs (ECA) to host nearly 100 Fulbright Foreign Students from around the world on April 24-28, 2019 at the Jacobs School on UB’s Downtown Campus for a three-day Fulbright Enrichment Seminar titled “Combating Addiction and Addressing the Opioid Crisis.”
Joshua Lynch, DO, and emergency medicine physicians in the Jacobs School have developed Buffalo MATTERS to expand emergency room treatment for opioid addiction. He shared its success with Lt. Gov. Kathy Hochul and Erie County Commissioner of Health Gale Burstein, MD.